Early identification of individuals at risk for cardiovascular disease, including myocardial infarction, stroke and peripheral vascular disease, has become increasingly important within the past decade as advances in therapy, including drug treatment as well as minimally invasive revascularization therapies, have enabled physicians to alter the course of disease and achieve significant improvements in patient outcome.